160 related articles for article (PubMed ID: 32805412)
1. Crossfibrillar mineral tessellation in normal and Hyp mouse bone as revealed by 3D FIB-SEM microscopy.
Buss DJ; Reznikov N; McKee MD
J Struct Biol; 2020 Nov; 212(2):107603. PubMed ID: 32805412
[TBL] [Abstract][Full Text] [Related]
2. Mineral tessellation in mouse enthesis fibrocartilage, Achilles tendon, and Hyp calcifying enthesopathy: A shared 3D mineralization pattern.
Buss DJ; Rechav K; Reznikov N; McKee MD
Bone; 2023 Sep; 174():116818. PubMed ID: 37295663
[TBL] [Abstract][Full Text] [Related]
3. Mineral tessellation in bone and the stenciling principle for extracellular matrix mineralization.
McKee MD; Buss DJ; Reznikov N
J Struct Biol; 2022 Mar; 214(1):107823. PubMed ID: 34915130
[TBL] [Abstract][Full Text] [Related]
4. Distinct roles for intrinsic osteocyte abnormalities and systemic factors in regulation of FGF23 and bone mineralization in Hyp mice.
Liu S; Tang W; Zhou J; Vierthaler L; Quarles LD
Am J Physiol Endocrinol Metab; 2007 Dec; 293(6):E1636-44. PubMed ID: 17848631
[TBL] [Abstract][Full Text] [Related]
5. Genetic Ablation of Osteopontin in Osteomalacic Hyp Mice Partially Rescues the Deficient Mineralization Without Correcting Hypophosphatemia.
Hoac B; Østergaard M; Wittig NK; Boukpessi T; Buss DJ; Chaussain C; Birkedal H; Murshed M; McKee MD
J Bone Miner Res; 2020 Oct; 35(10):2032-2048. PubMed ID: 32501585
[TBL] [Abstract][Full Text] [Related]
6. Contributions of increased osteopontin and hypophosphatemia to dentoalveolar defects in osteomalacic Hyp mice.
Mohamed FF; Hoac B; Phanrungsuwan A; Tan MH; Giovani PA; Ghiba S; Murshed M; Foster BL; McKee MD
Bone; 2023 Nov; 176():116886. PubMed ID: 37634682
[TBL] [Abstract][Full Text] [Related]
7. Dentoalveolar Defects in the
Zhang H; Chavez MB; Kolli TN; Tan MH; Fong H; Chu EY; Li Y; Ren X; Watanabe K; Kim DG; Foster BL
J Dent Res; 2020 Apr; 99(4):419-428. PubMed ID: 31977267
[TBL] [Abstract][Full Text] [Related]
8. Hormonal Regulation of Osteocyte Perilacunar and Canalicular Remodeling in the Hyp Mouse Model of X-Linked Hypophosphatemia.
Tokarz D; Martins JS; Petit ET; Lin CP; Demay MB; Liu ES
J Bone Miner Res; 2018 Mar; 33(3):499-509. PubMed ID: 29083055
[TBL] [Abstract][Full Text] [Related]
9. Impaired 1,25 dihydroxyvitamin D3 action and hypophosphatemia underlie the altered lacuno-canalicular remodeling observed in the Hyp mouse model of XLH.
Yuan Y; Jagga S; Martins JS; Rana R; Pajevic PD; Liu ES
PLoS One; 2021; 16(5):e0252348. PubMed ID: 34043707
[TBL] [Abstract][Full Text] [Related]
10. Osteocytes but not osteoblasts directly build mineralized bone structures.
Wang K; Ren Y; Lin S; Jing Y; Ma C; Wang J; Yuan XB; Han X; Zhao H; Wang Z; Zheng M; Xiao Y; Chen L; Olsen BR; Feng JQ
Int J Biol Sci; 2021; 17(10):2430-2448. PubMed ID: 34326685
[TBL] [Abstract][Full Text] [Related]
11. Tissue-specific mineralization defects in the periodontium of the Hyp mouse model of X-linked hypophosphatemia.
Coyac BR; Falgayrac G; Baroukh B; Slimani L; Sadoine J; Penel G; Biosse-Duplan M; Schinke T; Linglart A; McKee MD; Chaussain C; Bardet C
Bone; 2017 Oct; 103():334-346. PubMed ID: 28764922
[TBL] [Abstract][Full Text] [Related]
12. Excessive Osteocytic Fgf23 Secretion Contributes to Pyrophosphate Accumulation and Mineralization Defect in Hyp Mice.
Murali SK; Andrukhova O; Clinkenbeard EL; White KE; Erben RG
PLoS Biol; 2016 Apr; 14(4):e1002427. PubMed ID: 27035636
[TBL] [Abstract][Full Text] [Related]
13. Effects of Active Vitamin D or FGF23 Antibody on
Lira Dos Santos EJ; Chavez MB; Tan MH; Mohamed FF; Kolli TN; Foster BL; Liu ES
J Dent Res; 2021 Dec; 100(13):1482-1491. PubMed ID: 33906518
[TBL] [Abstract][Full Text] [Related]
14. Impaired mineral quality in dentin in X-linked hypophosphatemia.
Coyac BR; Falgayrac G; Penel G; Schmitt A; Schinke T; Linglart A; McKee MD; Chaussain C; Bardet C
Connect Tissue Res; 2018 Dec; 59(sup1):91-96. PubMed ID: 29745817
[TBL] [Abstract][Full Text] [Related]
15. Conductive Hearing Loss in the Hyp Mouse Model of X-Linked Hypophosphatemia Is Accompanied by Hypomineralization of the Auditory Ossicles.
Delsmann MM; Seist R; Stürznickel J; Schmidt FN; Mansour A; Kobelski MM; Broocks G; Peichl J; Oheim R; Praetorius M; Schinke T; Amling M; Demay MB; Stankovic KM; Rolvien T
J Bone Miner Res; 2021 Dec; 36(12):2317-2328. PubMed ID: 34523743
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of FGFR Signaling Partially Rescues Hypophosphatemic Rickets in HMWFGF2 Tg Male Mice.
Xiao L; Du E; Homer-Bouthiette C; Hurley MM
Endocrinology; 2017 Oct; 158(10):3629-3646. PubMed ID: 28938491
[TBL] [Abstract][Full Text] [Related]
17. Proteolytic processing of osteopontin by PHEX and accumulation of osteopontin fragments in Hyp mouse bone, the murine model of X-linked hypophosphatemia.
Barros NM; Hoac B; Neves RL; Addison WN; Assis DM; Murshed M; Carmona AK; McKee MD
J Bone Miner Res; 2013 Mar; 28(3):688-99. PubMed ID: 22991293
[TBL] [Abstract][Full Text] [Related]
18. Comparison of calcimimetic R568 and calcitriol in mineral homeostasis in the Hyp mouse, a murine homolog of X-linked hypophosphatemia.
Leifheit-Nestler M; Kucka J; Yoshizawa E; Behets G; D'Haese P; Bergen C; Meier M; Fischer DC; Haffner D
Bone; 2017 Oct; 103():224-232. PubMed ID: 28728941
[TBL] [Abstract][Full Text] [Related]
19. Sclerostin antibody improves alveolar bone quality in the Hyp mouse model of X-linked hypophosphatemia (XLH).
Carpenter KA; Alkhatib DO; Dulion BA; Guirado E; Patel S; Chen Y; George A; Ross RD
Int J Oral Sci; 2023 Oct; 15(1):47. PubMed ID: 37813865
[TBL] [Abstract][Full Text] [Related]
20. Defective Mineralization in X-Linked Hypophosphatemia Dental Pulp Cell Cultures.
Coyac BR; Hoac B; Chafey P; Falgayrac G; Slimani L; Rowe PS; Penel G; Linglart A; McKee MD; Chaussain C; Bardet C
J Dent Res; 2018 Feb; 97(2):184-191. PubMed ID: 28880715
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
